The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2015
Filed:
Dec. 20, 2013
Applicant:
Omnigen Research, L.l.c., Corvallis, OR (US);
Inventors:
Neil E. Forsberg, Corvallis, OR (US);
Steven B. Puntenney, Ione, OR (US);
Assignee:
OmniGen Research, LLC, Corvallis, OR (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/47 (2006.01); A61K 38/46 (2006.01); A23L 1/30 (2006.01); A23L 1/304 (2006.01); A23L 1/03 (2006.01); A23L 1/059 (2006.01); A23K 1/16 (2006.01); A23K 1/165 (2006.01); A23K 1/175 (2006.01); A61K 31/716 (2006.01); A61K 31/736 (2006.01); A61K 35/02 (2015.01); A61K 31/715 (2006.01); A61K 33/00 (2006.01); A61K 33/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/47 (2013.01); A23K 1/16 (2013.01); A23K 1/1643 (2013.01); A23K 1/1653 (2013.01); A23K 1/175 (2013.01); A23K 1/1756 (2013.01); A23L 1/031 (2013.01); A23L 1/034 (2013.01); A23L 1/0305 (2013.01); A23L 1/059 (2013.01); A23L 1/30 (2013.01); A23L 1/304 (2013.01); A61K 31/715 (2013.01); A61K 31/716 (2013.01); A61K 31/736 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 35/02 (2013.01); A61K 38/46 (2013.01); A23V 2200/324 (2013.01); A23V 2250/15 (2013.01); A23V 2250/156 (2013.01); A23V 2250/5034 (2013.01); A23V 2250/5058 (2013.01);
Abstract
A method for the augmentation of immune function is described. The invention comprises a combination of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to augment immune function. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.